Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C2 calcium-dependent domain-containing protein 4B is a member of the C2 domain-containing protein family. The C2 domain is approximately 130 residues and mediates calcium-dependent or calcium-independent membrane association in a range of signaling proteins[2][5]. Proteins with C2 domains are involved in membrane trafficking, signal transduction, lipid signaling, and protein phosphorylation, although not all C2 domains bind calcium and not all serve the same functional roles[2][5]. C2CD4B is expressed in several tissues, including the embryo endoderm and gut in mice[4]. There is currently no evidence that C2CD4B acts as a receptor, enzyme, transporter, or transcription factor, nor is it recognized as a therapeutic target or associated with specific human disease mechanisms in the current scientific literature. If further information or therapeutic targeting arises, these details should be updated accordingly. For now, C2CD4B is best classified as an "other" C2 domain-containing protein with unknown specific function or disease relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C2 calcium-dependent domain-containing protein 4B (C2CD4B).